Daily Aspirin May Not Prevent Bowel Cancer But Increases Bleeding Risk

Taking daily aspirin might not protect you from bowel cancer. New studies show it doesn't help much in the short term and can raise your risk of bleeding, like a stroke.
By Newsroom | Health, Medicine |

Many individuals have relied on daily low-dose aspirin, often advised for cardiovascular health. However, recent expert assessments and research suggest this practice may not offer the expected protection against certain cancers, while simultaneously introducing significant bleeding risks. The consensus is shifting, prompting a re-evaluation of aspirin's role in preventative medicine for the general population.

Aspirin's Dual Role: A Shifting Landscape

For years, daily aspirin, particularly low-dose formulations, has been a common recommendation. Its known effect on blood clotting led to its use in preventing heart attacks and strokes, especially for those with existing cardiovascular conditions. However, a growing body of evidence is challenging its broader application, particularly in cancer prevention. Experts now question whether the perceived benefits outweigh the immediate and potentially severe risks associated with its regular use. This re-evaluation stems from recent analyses of large-scale studies and systematic reviews that paint a more nuanced, and in some areas, a less optimistic picture of aspirin's efficacy and safety profile.

Read More: Older Adults with Chronic Illnesses Show Low Awareness of Shingles Risk in India

  • Historical Context: Aspirin's anti-clotting properties have long been recognized, leading to its widespread adoption for primary and secondary cardiovascular event prevention.

  • Emerging Concerns: Newer research highlights potential risks, especially bleeding events, and questions its effectiveness for conditions like bowel cancer prevention in the general population.

  • Expert Reassessment: A notable shift is occurring among medical experts and research bodies regarding the routine use of aspirin for non-specific preventative measures.

Examining Aspirin's Impact on Bowel Cancer Prevention

The notion that daily aspirin can prevent bowel cancer in the general population is increasingly being disputed by experts. Research indicates it does not offer a quick or reliable protective effect and may carry immediate risks of serious bleeding.

A comprehensive Cochrane review, analyzing multiple studies, found that aspirin likely does not reduce the number of new bowel cancer cases within the first 5 to 15 years of use. While some data suggests a potential reduction after 15 years, the confidence in this finding is low. Furthermore, some studies even suggest that aspirin might increase colorectal cancer mortality within 5 to 10 years of follow-up.

  • Short-Term Efficacy: Evidence suggests little to no short-term benefit in preventing bowel cancer.

  • Long-Term Uncertainty: The long-term effects remain uncertain, with some data suggesting a possible benefit after extended periods, but with low confidence.

  • Bleeding Risk: A significant concern is the immediate and well-established risk of serious bleeding associated with aspirin use.

Aspirin and Stroke Risk: A Re-evaluation of Benefits

Recent research suggests that daily low-dose aspirin has a limited impact on reducing stroke incidence in healthy older individuals and can increase the risk of brain bleeding, particularly in the event of falls.

Read More: Neurologists Say Lifestyle Changes Can Cut Dementia Risk by Half

Analysis of data from large clinical trials indicates that there is no statistically significant difference in stroke incidence between individuals taking aspirin and those receiving a placebo. Simultaneously, these studies have found that low-dose aspirin use may increase the risk of intracerebral bleeding, a type of hemorrhagic stroke. This is especially concerning in older adults who may be more susceptible to falls.

  • Stroke Incidence: Studies found no significant reduction in overall stroke rates among aspirin users compared to placebo groups.

  • Hemorrhagic Stroke Risk: Aspirin appears to elevate the risk of bleeding within the brain, which can occur due to trauma like falls.

  • Cardiovascular Exception: These findings are generally not applicable to individuals already taking aspirin as prescribed for a known cardiovascular condition.

The Bleeding Risk: A Tangible Concern

A consistent finding across multiple investigations is the elevated risk of bleeding, including serious gastrointestinal bleeding and hemorrhagic stroke, associated with daily aspirin intake.

Aspirin's mechanism of reducing blood clotting, while beneficial for preventing certain cardiovascular events, also inherently increases the propensity for bleeding. This risk is immediate and not dependent on long-term use. Researchers from West China Hospital of Sichuan University, analyzing data from over 124,000 participants, highlighted that patients should not initiate aspirin for cancer prevention without a thorough discussion with their healthcare provider regarding their personal bleeding risk. The potential long-term benefits, if any, must be carefully weighed against these immediate and established risks.

Read More: UK Assisted Dying Law Faces Delays Due to Lack of Service Plans

  • Gastrointestinal Bleeding: Aspirin is a known cause of upper gastrointestinal bleeding.

  • Intracranial Hemorrhage: The risk of bleeding in the brain, or hemorrhagic stroke, is a significant concern, particularly in older adults.

  • Surgical Implications: Individuals on daily aspirin therapy must inform their care teams if surgery is planned, as it can complicate procedures.

Anemia and Other Side Effects

Beyond bleeding, evidence also points to a potential increase in anemia risk among older adults who regularly take daily low-dose aspirin.

The ASPREE trial, which investigated aspirin's effects in healthy older adults, also revealed a possible link between daily aspirin use and an increased risk of anemia. While the exact mechanisms are still being explored, this adds another layer of concern for those considering long-term, preventative aspirin therapy without a clear medical indication. Allergic reactions, though less common, are also a possibility for some individuals.

  • Anemia Link: Some studies suggest a higher incidence of anemia in elderly individuals taking daily aspirin.

  • Allergic Reactions: As with any medication, aspirin can trigger allergic responses in susceptible individuals.

Expert Perspectives and Recommendations

"The authors urge that patients should not start taking aspirin for cancer prevention without a careful conversation with their healthcare professional about their personal risk of bleeding."— Researchers from West China Hospital of Sichuan University

"These recommendations do not apply to individuals taking aspirin for a known cardiovascular condition."— National Institute on Aging (NIA)

"Aspirin probably does not make any difference to the number of new bowel cancer cases after 5 to 15 years of follow-up. After 15 years, aspirin may reduce the number of new bowel cancer cases, but we are not confident in this result."— Cochrane Review Authors

Conclusion and Implications

The current body of evidence indicates that daily aspirin use for the general population's bowel cancer prevention is not supported by robust short-term data and carries immediate bleeding risks. Similarly, its impact on stroke prevention for healthy older adults appears limited, while the risk of brain bleeding is a tangible concern. These findings necessitate a more cautious approach to prescribing or recommending daily aspirin for primary prevention.

Read More: New Pulmonary Embolism Guidelines Change Patient Care Levels in Hospitals

  • For Cancer Prevention: Individuals considering aspirin for bowel cancer prevention should be aware of the uncertain long-term benefits and the immediate risks of bleeding. A thorough discussion with a healthcare provider is essential.

  • For Cardiovascular Prevention: The established benefits of aspirin for individuals with known cardiovascular disease remain relevant, but the risks, particularly bleeding, must be managed.

  • Future Research: Further investigation is needed to clarify the long-term effects of aspirin on cancer, especially in specific high-risk populations, and to better understand the balance of risks and benefits across diverse demographic groups.

Sources:

Frequently Asked Questions

Q: Why are experts changing their advice on daily aspirin for bowel cancer?
New research suggests daily aspirin does not reliably prevent bowel cancer, especially in the first 5 to 15 years. Experts are concerned that the immediate risks of serious bleeding outweigh the uncertain benefits for the general population.
Q: What are the main risks of taking daily low-dose aspirin?
The main risks are serious bleeding, such as in the stomach or brain (hemorrhagic stroke). This risk is present from the start of taking aspirin and is a significant concern, especially for older adults or those who might fall.
Q: Does daily aspirin help prevent strokes in healthy older people?
Recent studies show that daily low-dose aspirin has little to no significant effect on preventing strokes in healthy older adults. It also increases the risk of bleeding in the brain, which can be a type of stroke.
Q: Are there any other side effects from taking daily aspirin?
Besides bleeding, some studies suggest that older adults taking daily aspirin may have a higher risk of developing anemia. Allergic reactions are also possible, though less common.
Q: Should people stop taking aspirin if they already use it for heart problems?
No, these new recommendations generally do not apply to people who are already taking aspirin as prescribed by their doctor for known heart or blood vessel conditions. Their doctors will manage their risks.
Q: What should I do if I am thinking about taking aspirin for prevention?
You should talk to your doctor before starting daily aspirin for any prevention. They will help you understand your personal risks, especially your risk of bleeding, and decide if the potential benefits are right for you.